{
    "name": "vilobelimab",
    "comment": "Investigational",
    "other_names": [
        "Gohibic"
    ],
    "classes": [
        "Complement Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/gohibic-vilobelimab-4000305",
    "pregnancy": {
        "common": [
            "There are no available data on use in pregnant females to evaluate for a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes",
            "Placental transfer of monoclonal antibodies is greater during third trimester of pregnancy; therefore, potential effects on a fetus are likely to be greater during that time"
        ],
        "specific": [
            {
                "type": "Animal studies ",
                "description": [
                    "In an enhanced pre- and post-natal (ePPND) study conducted in cynomolgus monkeys, placental transport of vilobelimab was observed, but there was no evidence of fetal harm following IV administration throughout pregnancy at doses 2.5 times the maximum recommended human dose (MRHD) of 800 mg on a mg/kg basis"
                ]
            }
        ]
    },
    "lactation": {
        "common": []
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Death or life",
            "percent": "3500"
        },
        {
            "name": "threatening adverse event",
            "percent": "5600"
        },
        {
            "name": "Medical or surgical intervention to prevent death",
            "percent": "20852-9787,"
        },
        {
            "name": "life",
            "percent": "1-800"
        },
        {
            "name": "threatening event",
            "percent": "0178,"
        },
        {
            "name": "hospitalization",
            "percent": "1-800"
        },
        {
            "name": "disability",
            "percent": "1088"
        },
        {
            "name": "or congenital anomaly",
            "percent": null
        },
        {
            "name": "Inpatient hospitalization or prolongation of existing hospitalization",
            "percent": null
        },
        {
            "name": "Persistent or significant incapacity or substantial disruption of ability to conduct normal life functions",
            "percent": null
        },
        {
            "name": "or",
            "percent": null
        },
        {
            "name": "Congenital anomaly",
            "percent": null
        },
        {
            "name": "birth defect",
            "percent": null
        },
        {
            "name": "Complete and submit the report online",
            "percent": null
        },
        {
            "name": "Complete and submit a postage",
            "percent": null
        },
        {
            "name": "paid FDA Form",
            "percent": null
        },
        {
            "name": "and mail to MedWatch",
            "percent": null
        },
        {
            "name": "Fishers Lane",
            "percent": null
        },
        {
            "name": "Rockville",
            "percent": null
        },
        {
            "name": "MD",
            "percent": null
        },
        {
            "name": "or",
            "percent": null
        },
        {
            "name": "Fax to",
            "percent": null
        },
        {
            "name": "FDA",
            "percent": null
        },
        {
            "name": "or Call",
            "percent": null
        },
        {
            "name": "FDA",
            "percent": null
        },
        {
            "name": "to request a reporting form",
            "percent": null
        }
    ]
}